Abbott launches Libre Assist for in-the-moment food decisions

RedHill advances RHB-102 across GI indications

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

BioInvent reports encouraging Phase 2a data for BI-1808 plus pembrolizumab in recurrent ovarian cancer

FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes

Hoth Therapeutics files two US provisional patent applications to establish oncology-focused dermatology platform

Insilico Medicine signs multi-year research and development collaboration with Servier

Samsung Bioepis begins direct commercialisation of BYOOVIZ in Europe

MemorialCare hospitals recognised in 2026 Women's Choice Awards

International Isotopes Inc to change name to Radnostix Inc

Elanco Animal Health's Befrena (tirnovetmab) receives USDA approval for canine dermatitis

Delcath publishes Phase 3 FOCUS subgroup data supporting HEPZATO in metastatic uveal melanoma

Corcept announces receipt of FDA Complete Response letter for relacorilant in hypercortisolism

Sensiva Health names new chief operating officer

HUTCHMED savolitinib NDA for MET-amplified gastric cancer accepted for priority review in China